Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1

Archives of Dermatology

Volumn 133, Issue 7, 1997, Pages 853-857

  Darling, Thomas N ^a,b   Skarulis, Monica C ^b   Steinberg, Seth M ^a   Marx, Stephen J ^b   Spiegel, Allen M ^b   Turner, Maria ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CAFE AU LAIT SPOT; CLINICAL ARTICLE; CONTROLLED STUDY; FACE TUMOR; FAMILY HISTORY; FEMALE; GINGIVA DISEASE; HEMANGIOFIBROMA; HUMAN; HYPERPARATHYROIDISM; HYPOPIGMENTATION; LIPOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; SKIN MANIFESTATION; TUBEROUS SCLEROSIS;

EID: 0030748358     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.7.853     Document Type: Article

References (17)

1. Metz DC, Jensen RT, Bale A, et al. Multiple endocrine neoplasia type 1: clinical features and management. In: Bilezekian JP, Levine MA, Marcus R, eds. The Parathyroids. New York, NY: Raven Press; 1994:591-646.
2. Marx SJ, Vinik AI, Santen RJ, Floyd JC, Mills JL, Green J. Multiple endocrine neoplasia type 1: assessment of laboratory tests to screen for the gene in a large kindred. Medicine. 1986;65:226-241.
3. Larsson C, Skogreid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinomas. Nature. 1988;332:85-87.
4. Friedman E, Sakaguchi K, Bale AE, et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med. 1989;321:213-218.
5. Larsson C, Nordenskjold M. Family screening in multiple endocrine neoplasia type 1 (MEN 1). Ann Med. 1994;26:191-198.
6. Morelli A, Falchetti A, Castello R, et al. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. J Endocrinol Invest. 1995;18:329-335.
7. Ballard HS, Frame B, Hartsock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine. 1964;43:481-512.
8. Yoshimoto K, Saito S. Clinical characteristics in multiple endocrine neoplasia type 1 in Japan: a review of 106 patients. Nippon Naibunpi Gakkai Zasshi. 1991;67:746-753.
9. Jonckheere AR. A distribution-free K-sample test against ordered alternatives. Biometrika. 1954;41:133-145.
10. Lygidakis NA, Lindenbaum RH. Oral fibromatosis in tuberous sclerosis. Oral Surg Oral Med Oral Pathol. 1989;68:725-728.
11. Mignogna MD, Muzio LL, Ruocco V, Bucci E. Early diagnosis of multiple hamartoma and neoplasia syndrome (Cowden disease): the role of the dentist Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:295-299.
12. Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L. Diagnostic criteria: tuberous sclerosis complex. J Child Neurol. 1992;7:221-224.
13. Kwiatkowski DJ, Short MP. Tuberous sclerosis. Arch Dermatol. 1994:130:348-354.
14. Rogers R. Dermatologic manifestations. In: Gomez MR, ed. Tuberous Sclerosis. New York, NY: Raven Press; 1979:95-119.
15. Ruquena L, Gutierrez J, Sanchez-Yus E. Multiple sclerotic fibromas of the skin: a cutaneous marker of Cowden's disease. J Cutan Pathol. 1991;19:346-351.
16. McLean DI, Gallagher RP. 'Sunburn' freckles, cafe-au-lait macules, and other pigmented lesions of schoolchildren: the Vancouver Mole Study. J Am Acad Dermatol. 1995;32:565-570.
17. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-407.